Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · as published 2026-01-23 View official record Methodology

Covered recipient · General Payments record

MARC BRAUNSTEIN

Allopathic & Osteopathic Physicians Internal Medicine Hematology & Oncology

NPI
1568761336
CMS profile
1389199
Location
MINEOLA, NY

General Payments · PY2018–2024

$120,073.52

  • Reported across 131 records
  • CMS publication 2026-01-23

Latest program year · PY2024

$22,380.90

23 records · 0 disputed

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How these totals are calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

PY2024 · sorted by reported total

By paying entity

PY2024 · sorted by reported total

Paying entityAmountRecords
Acerta Pharma LLC $5,460.00 5
GENZYME CORPORATION $5,035.79 5
E.R. Squibb & Sons, L.L.C. $3,850.00 2
Janssen Biotech, Inc. $2,340.00 1
Ipsen Biopharmaceuticals, Inc $2,180.21 2
ABBVIE INC. $2,025.00 1
BeiGene USA, Inc. $704.50 2
Daiichi Sankyo Inc. $525.00 1
SOBI, INC $200.00 1
Genmab U.S., Inc. $26.36 1
Kite Pharma, Inc. $17.73 1
Lilly USA, LLC $16.31 1

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2018 $13,635.26 20
PY2019 $3,383.07 7
PY2020 $22,490.66 18
PY2021 $17,712.29 15
PY2022 $21,031.10 22
PY2023 $19,440.24 26
PY2024 $22,380.90 23

Payment records · PY2024 (23)

Sorted by paying entity, then date · as published by CMS

Program year 2024 201820192020202120222023 Record-level detail is published for PY2024; earlier years are summarised in “By program year”.
Paying entity Amount Date Nature of payment Dispute status Published Record ID Source
ABBVIE INC. $2,025.00 08/26/2024 Consulting Fee Undisputed 01/23/2026 1103132353 CMS
AstraZeneca Pharmaceuticals LP $525.00 05/22/2024 Consulting Fee Undisputed 01/23/2026 1105473379 CMS
AstraZeneca Pharmaceuticals LP $1,942.50 07/22/2024 Consulting Fee Undisputed 01/23/2026 1104232965 CMS
AstraZeneca Pharmaceuticals LP $525.00 08/01/2024 Consulting Fee Undisputed 01/23/2026 1104573012 CMS
AstraZeneca Pharmaceuticals LP $1,942.50 09/03/2024 Consulting Fee Undisputed 01/23/2026 1105758427 CMS
AstraZeneca Pharmaceuticals LP $525.00 12/12/2024 Consulting Fee Undisputed 01/23/2026 1105332078 CMS
BeiGene USA, Inc. $29.50 10/29/2024 Food and Beverage Undisputed 01/23/2026 1120856745 CMS
BeiGene USA, Inc. $675.00 11/26/2024 Consulting Fee Undisputed 01/23/2026 1120856743 CMS
Daiichi Sankyo Inc. $525.00 11/02/2024 Consulting Fee Undisputed 01/23/2026 1084193860 CMS
E.R. Squibb & Sons, L.L.C. $1,650.00 01/19/2024 Consulting Fee Undisputed 01/23/2026 1101557389 CMS
E.R. Squibb & Sons, L.L.C. $2,200.00 07/26/2024 Consulting Fee Undisputed 01/23/2026 1101557458 CMS
Genmab U.S., Inc. $26.36 02/16/2024 Food and Beverage Undisputed 01/23/2026 1126829244 CMS
GENZYME CORPORATION $197.11 05/15/2024 Food and Beverage Undisputed 01/23/2026 1139904805 CMS
GENZYME CORPORATION $3,324.00 05/15/2024 Consulting Fee Undisputed 01/23/2026 1139904807 CMS
GENZYME CORPORATION $28.84 05/15/2024 Travel and Lodging Undisputed 01/23/2026 1139904809 CMS
GENZYME CORPORATION $654.84 06/21/2024 Travel and Lodging Undisputed 01/23/2026 1139904785 CMS
GENZYME CORPORATION $831.00 06/21/2024 Consulting Fee Undisputed 01/23/2026 1139904787 CMS
Ipsen Biopharmaceuticals, Inc $110.21 10/17/2024 Food and Beverage Undisputed 01/23/2026 1091992985 CMS
Ipsen Biopharmaceuticals, Inc $2,070.00 10/17/2024 Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program Undisputed 01/23/2026 1091992987 CMS
Janssen Biotech, Inc. $2,340.00 07/26/2024 Consulting Fee Undisputed 01/23/2026 1078436894 CMS
Kite Pharma, Inc. $17.73 10/29/2024 Food and Beverage Undisputed 01/23/2026 1128609579 CMS
Lilly USA, LLC $16.31 04/18/2024 Food and Beverage Undisputed 01/23/2026 1135164659 CMS
SOBI, INC $200.00 08/07/2024 Consulting Fee Undisputed 01/23/2026 1141435293 CMS

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-01-23
Program years on this page
2018, 2019, 2020, 2021, 2022, 2023, 2024
Source files
Dataset page · Bulk file · PY2018 , PY2019 , PY2020 , PY2021 , PY2022 , PY2023 , PY2024
Generated from
OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.